Work

The novel SPPARM YR3–16 ameliorates metabolic disorders in vivo and attenuates adipocyte inflammation in vitro via PPARγ-dependent ERK suppression

Year: 2026

Type: article

Source: International Immunopharmacology

DOI: 10.1016/j.intimp.2026.116320

Authors: Cunyu Feng, Quan Liu, Jun Peng, Chunming Jia, Xuan Pan, Shuainan Liu, Xiaohui Geng, Jiayu Zhai, Min Wu, Siming Hao, Liran Lei, Kejia Xu, Yuting Ma, Lei Lei, Zhanzhu Liu, Yi Huan, Zhufang Shen

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Third Affiliated Hospital of Sun Yat-sen University

Language: English

Topic: Peroxisome Proliferator-Activated Receptors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Natural Science Foundation of China, National Major Science and Technology Projects of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Awards: G1633835211, G2097963897, G21068814, G3027779784

OpenAlex ID: W7128361517

FWCI: 2.044

Cites: 36

Cited by: 1

Related to: 10